ClinConnect ClinConnect Logo
Search / Trial NCT04199676

Immediate Postpartum Glucose Tolerance Testing

Launched by MEMORIALCARE HEALTH SYSTEM · Dec 12, 2019

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how well a glucose tolerance test, done right after giving birth, can help in managing gestational diabetes. Typically, women with gestational diabetes have a glucose test about six weeks after they give birth to check their blood sugar levels. This study aims to see if doing the test during the hospital stay after delivery is more accurate and encourages more women to get tested.

To participate, women need to be at least 18 years old, have been pregnant for at least 34 weeks, and have been diagnosed with A1 or A2 gestational diabetes. They should be either pregnant or just had their baby. If someone has certain medical conditions or has used steroids recently, they may not be eligible. Participants will take the glucose test while still in the hospital, and the goal is to find out if this approach leads to better testing and monitoring for those who had gestational diabetes.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Pregnant or recently postpartum (postpartum day 0 or 1)
  • ≥ 18 years of age
  • Gestational age ≥34 weeks
  • A1 or A2 gestational diabetes
  • Exclusion Criteria:
  • Medical exclusion from completing glucose tolerance testing
  • Steroid administration within 10 days prior to enrollment
  • Chronic steroid use

About Memorialcare Health System

MemorialCare Health System is a prominent integrated healthcare organization based in Southern California, dedicated to providing high-quality, patient-centered care across a diverse range of medical services. With a strong commitment to clinical excellence, MemorialCare conducts innovative clinical trials that advance medical research and improve treatment outcomes. The organization operates several leading hospitals, outpatient facilities, and specialized care centers, leveraging cutting-edge technology and a collaborative approach to enhance the health and well-being of the communities it serves. MemorialCare's focus on research and development underscores its mission to deliver breakthrough therapies and foster advancements in healthcare.

Locations

Long Beach, California, United States

Patients applied

0 patients applied

Trial Officials

Kenneth Chan, MD

Principal Investigator

Magella Medical Group

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials